The National Agency for Food and Drug Administration and Control has alerted Nigerians to the illegal manufacture and sale of unregistered B-GAG mist pot CIT syrup.
The alert is contained in a public notice No. 023/2024, issued by the agency’s Director-General, Prof. Mojisola Adeyeye, in Abuja on Sunday.
Babban Gida Agalawa General Enterprises is accused of selling an unregistered product.
According to the statement, the product, being presented in a pet bottle, was discovered during a surveillance operation carried out by the NAFDAC Post Marketing Surveillance Directorate Officers in Maiduguri, Borno, and Keffi, Nasarawa States.
It said that the product was found to be without a NAFDAC registration number and a misleading label.
According to NAFDAC’s statement, illegal marketing of medicines or counterfeit medicines endangers public health.
Adeyeye stated that without compliance with regulatory provisions for safety, the quality and efficacy of such products were not guaranteed.
The agency assigned the fake product a batch number of 0070, a manufacturing date of 01/02/2024, and an expiration date of 01/02/2027.
Adeyeye also gave the address of the manufacturer as No. 883/884 Western Bypass Ring Road, Kumbosto Local Government, Kano State.
Adeyeye further said that NAFDAC Zonal Directors and State Coordinators had been directed to carry out surveillance to mop up the illegal products within the zones and states.
She advised consumers and caregivers to avoid the use of the product, adding that all medical products must be obtained from authorised and licensed suppliers.
Adeyeye said that products’ authenticity and physical condition should be carefully checked before buying.
She also advised healthcare professionals and consumers to report any suspicion of either the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office.
Adeyeye called on the public to report any adverse reaction to NAFDAC on 0800-162-3322 or via email: [email protected].
She encouraged healthcare professionals and patients to report adverse events or side effects related to the use of medicinal products through NAFDAC E-reporting platforms.
According to her, the e-reporting platforms are www.nafdac.gov.ng, the Med-safety app, which can be downloaded from the Android and iOS stores, or via email at [email protected].
She stated that the product notice would be uploaded to the World Health Organization’s Global Surveillance and Monitoring System.
